+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Women's Health Diagnostics Market Research Report by Type, Application, End-User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 139 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5124643
UP TO OFF until Mar 31st 2023
The United States Women’s Health Diagnostics Market size was estimated at USD 8,764.06 million in 2022, USD 9,436.20 million in 2023 and is projected to grow at a CAGR of 8.29% to reach USD 16,577.48 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Women’s Health Diagnostics Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Women’s Health Diagnostics Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Women’s Health Diagnostics Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Women’s Health Diagnostics Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Women’s Health Diagnostics Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Type, the market is studied across Point-of-Care and Self Check.
  • Based on Application, the market is studied across Breast Cancer Testing, Cervical Cancer Testing, Infectious Disease Testing, Osteoporosis Testing, Ovarian Cancer Testing, Pregnancy & Fertility Testing, Prenatal Genetic Screening & Carrier Testing, Sexually Transmitted Disease Testing, and Ultrasound Tests. The Breast Cancer Testing is is further studied across Biopsies, Blood Chemistries & Blood Cell Count Tests, Breast Cancer Tumor Marker Tests, and Mammography. The Cervical Cancer Testing is is further studied across HPV Testing and PAP Smear. The Infectious Disease Testing is is further studied across HEPAtitis Testing, MRSA Testing, Tuberculosis Testing, and Urinary Tract Infection Testing (Vaginal pH & Vaginitis). The Osteoporosis Testing is is further studied across Bone Densitometry and in Vitro Blood Tests. The Ovarian Cancer Testing is is further studied across Diagnostic Imaging Tests and Ovarian Cancer Tumor Marker Tests. The Pregnancy & Fertility Testing is is further studied across Fertility Monitors, Lab-Based Testing, and Pregnancy Testing & Ovulation Prediction Kits. The Prenatal Genetic Screening & Carrier Testing is is further studied across Cystic Fibrosis, Down Syndrome & Edwards Syndrome, and Torch Infections. The Sexually Transmitted Disease Testing is is further studied across Chlamydia Trachomatis & Neisseria Gonorrhoeae (CT/NG) Testing and HIV Testing. The Ultrasound Tests is is further studied across Breast Imaging and OB/GYN Imaging.
  • Based on End-User, the market is studied across Diagnostic & Imaging Centers, Home Care, and Hospitals & Clinics.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Women’s Health Diagnostics Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Women’s Health Diagnostics Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Women’s Health Diagnostics Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Women’s Health Diagnostics Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Women’s Health Diagnostics Market, including Abbott Laboratories, AccuBioTech Co., Ltd., Alere Inc., Becton, Dickinson and Company, Biomérieux SA, Cardinal Health, Inc., Carestream Health, Inc., Chembio Diagnostic Systems, Inc., Cook Medical, Inc., Danaher Corporation, DIALAB GmbH, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., FUJIFILM Holdings Corporation, GE Healthcare, Guided Therapeutics, Inc., Hologic, Inc., Koninklijke Philips N.V., MedGyn Products, Inc., NeuroLogica Corporation, Nova Biomedical, Osteometer MediTech, Inc., Perkinelmer Inc., Quest Diagnostics Incorporated, Siemens AG, SuperSonic Imagine, and WerfenLife, S.A..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Women’s Health Diagnostics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Women’s Health Diagnostics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Women’s Health Diagnostics Market?
4. What is the competitive strategic window for opportunities in the United States Women’s Health Diagnostics Market?
5. What are the technology trends and regulatory frameworks in the United States Women’s Health Diagnostics Market?
6. What is the market share of the leading vendors in the United States Women’s Health Diagnostics Market?
7. What modes and strategic moves are considered suitable for entering the United States Women’s Health Diagnostics Market?
Frequently Asked Questions about the U.S. Women’s Health Diagnostics Market

What is the estimated value of the U.S. Women’s Health Diagnostics Market?

The U.S. Women’s Health Diagnostics Market was estimated to be valued at $8764.06 Million in 2022.

What is the growth rate of the U.S. Women’s Health Diagnostics Market?

The growth rate of the U.S. Women’s Health Diagnostics Market is 8.2%, with an estimated value of $16577.48 Million by 2030.

What is the forecasted size of the U.S. Women’s Health Diagnostics Market?

The U.S. Women’s Health Diagnostics Market is estimated to be worth $16577.48 Million by 2030.

Who are the key companies in the U.S. Women’s Health Diagnostics Market?

Key companies in the U.S. Women’s Health Diagnostics Market include Abbott Laboratories, AccuBioTech Co., Ltd., Alere Inc., Becton, Dickinson and Company, Biomérieux SA, Cardinal Health, Inc., Carestream Health, Inc., Chembio Diagnostic Systems, Inc. and Danaher Corporation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of infectious diseases, such as hepatitis and urinary tract infection, among women
5.1.1.2. Increased adoption of point-of-care and rapid diagnostic tests
5.1.2. Restraints
5.1.2.1. High cost of diagnostic imaging systems
5.1.3. Opportunities
5.1.3.1. Increasing approvals for women’s diagnostics techniques
5.1.4. Challenges
5.1.4.1. Strict regulatory guidelines
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Women’s Health Diagnostics Market, by Type
6.1. Introduction
6.2. Point-of-Care
6.3. Self Check

7. Women’s Health Diagnostics Market, by Application
7.1. Introduction
7.2. Breast Cancer Testing
7.3.1. Biopsies
7.3.2. Blood Chemistries & Blood Cell Count Tests
7.3.3. Breast Cancer Tumor Marker Tests
7.3.4. Mammography
7.3. Cervical Cancer Testing
7.4.1. HPV Testing
7.4.2. PAP Smear
7.4. Infectious Disease Testing
7.5.1. HEPAtitis Testing
7.5.2. MRSA Testing
7.5.3. Tuberculosis Testing
7.5.4. Urinary Tract Infection Testing (Vaginal pH & Vaginitis)
7.5. Osteoporosis Testing
7.6.1. Bone Densitometry
7.6.2. in Vitro Blood Tests
7.6. Ovarian Cancer Testing
7.7.1. Diagnostic Imaging Tests
7.7.2. Ovarian Cancer Tumor Marker Tests
7.7. Pregnancy & Fertility Testing
7.8.1. Fertility Monitors
7.8.2. Lab-Based Testing
7.8.3. Pregnancy Testing & Ovulation Prediction Kits
7.8. Prenatal Genetic Screening & Carrier Testing
7.9.1. Cystic Fibrosis
7.9.2. Down Syndrome & Edwards Syndrome
7.9.3. Torch Infections
7.9. Sexually Transmitted Disease Testing
7.10.1. Chlamydia Trachomatis & Neisseria Gonorrhoeae (CT/NG) Testing
7.10.2. HIV Testing
7.10. Ultrasound Tests
7.11.1. Breast Imaging
7.11.2. OB/GYN Imaging

8. Women’s Health Diagnostics Market, by End-User
8.1. Introduction
8.2. Diagnostic & Imaging Centers
8.3. Home Care
8.4. Hospitals & Clinics

9. California Women’s Health Diagnostics Market
9.1. Introduction

10. Florida Women’s Health Diagnostics Market
10.1. Introduction

11. Illinois Women’s Health Diagnostics Market
11.1. Introduction

12. New York Women’s Health Diagnostics Market
12.1. Introduction

13. Ohio Women’s Health Diagnostics Market
13.1. Introduction

14. Pennsylvania Women’s Health Diagnostics Market
14.1. Introduction

15. Texas Women’s Health Diagnostics Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Product Portfolio Analysis, By Key Player
16.5. Competitive Scenario
16.5.1. Merger & Acquisition
16.5.2. Agreement, Collaboration, & Partnership
16.5.3. New Product Launch & Enhancement
16.5.4. Investment & Funding
16.5.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Abbott Laboratories
17.2. AccuBioTech Co., Ltd.
17.3. Alere Inc.
17.4. Becton, Dickinson and Company
17.5. Biomérieux SA
17.6. Cardinal Health, Inc.
17.7. Carestream Health, Inc.
17.8. Chembio Diagnostic Systems, Inc.
17.9. Cook Medical, Inc.
17.10. Danaher Corporation
17.11. DIALAB GmbH
17.12. EKF Diagnostics Holdings plc
17.13. F. Hoffmann-La Roche Ltd.
17.14. FUJIFILM Holdings Corporation
17.15. GE Healthcare
17.16. Guided Therapeutics, Inc.
17.17. Hologic, Inc.
17.18. Koninklijke Philips N.V.
17.19. MedGyn Products, Inc.
17.20. NeuroLogica Corporation
17.21. Nova Biomedical
17.22. Osteometer MediTech, Inc.
17.23. Perkinelmer Inc.
17.24. Quest Diagnostics Incorporated
17.25. Siemens AG
17.26. SuperSonic Imagine
17.27. WerfenLife, S.A.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET DYNAMICS
FIGURE 8. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY TYPE, 2030
FIGURE 12. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 15. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2030
FIGURE 17. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES & BLOOD CELL COUNT TESTS, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
FIGURE 31. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, 2018-2030 (USD MILLION)
FIGURE 38. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, 2018-2030 (USD MILLION)
FIGURE 39. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING & OVULATION PREDICTION KITS, 2018-2030 (USD MILLION)
FIGURE 40. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
FIGURE 41. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, 2018-2030 (USD MILLION)
FIGURE 42. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME & EDWARDS SYNDROME, 2018-2030 (USD MILLION)
FIGURE 43. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, 2018-2030 (USD MILLION)
FIGURE 44. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHOEAE (CT/NG) TESTING, 2018-2030 (USD MILLION)
FIGURE 46. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, 2018-2030 (USD MILLION)
FIGURE 47. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
FIGURE 48. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, 2018-2030 (USD MILLION)
FIGURE 49. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, 2018-2030 (USD MILLION)
FIGURE 50. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 51. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 52. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USER, 2030
FIGURE 53. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, 2018-2030 (USD MILLION)
FIGURE 54. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
FIGURE 55. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
FIGURE 56. CALIFORNIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. FLORIDA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. ILLINOIS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. NEW YORK WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. OHIO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. PENNSYLVANIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. TEXAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 64. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 65. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SELF CHECK, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BIOPSIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES & BLOOD CELL COUNT TESTS, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BLOOD CHEMISTRIES & BLOOD CELL COUNT TESTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST CANCER TUMOR MARKER TESTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MAMMOGRAPHY, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CERVICAL CANCER TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HPV TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PAP SMEAR, BY STATE, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HEPATITIS TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY MRSA TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TUBERCULOSIS TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS), BY STATE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OSTEOPOROSIS TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BONE DENSITOMETRY, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY IN VITRO BLOOD TESTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC IMAGING TESTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OVARIAN CANCER TUMOR MARKER TESTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY & FERTILITY TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY FERTILITY MONITORS, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY LAB-BASED TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING & OVULATION PREDICTION KITS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PREGNANCY TESTING & OVULATION PREDICTION KITS, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY PRENATAL GENETIC SCREENING & CARRIER TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CYSTIC FIBROSIS, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME & EDWARDS SYNDROME, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DOWN SYNDROME & EDWARDS SYNDROME, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TORCH INFECTIONS, BY STATE, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY SEXUALLY TRANSMITTED DISEASE TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHOEAE (CT/NG) TESTING, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY CHLAMYDIA TRACHOMATIS & NEISSERIA GONORRHOEAE (CT/NG) TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HIV TESTING, BY STATE, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY ULTRASOUND TESTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY BREAST IMAGING, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, 2018-2030 (USD MILLION)
TABLE 76. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY OB/GYN IMAGING, BY STATE, 2018-2030 (USD MILLION)
TABLE 77. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 78. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, 2018-2030 (USD MILLION)
TABLE 79. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 80. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2018-2030 (USD MILLION)
TABLE 81. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY STATE, 2018-2030 (USD MILLION)
TABLE 82. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2018-2030 (USD MILLION)
TABLE 84. CALIFORNIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 85. CALIFORNIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 86. CALIFORNIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. CALIFORNIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. FLORIDA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 89. FLORIDA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. FLORIDA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. FLORIDA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. ILLINOIS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 93. ILLINOIS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. ILLINOIS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. ILLINOIS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. NEW YORK WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 97. NEW YORK WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 98. NEW YORK WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. NEW YORK WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. OHIO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 101. OHIO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. OHIO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. OHIO WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. PENNSYLVANIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 105. PENNSYLVANIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. PENNSYLVANIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 107. PENNSYLVANIA WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. TEXAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 109. TEXAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. TEXAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. TEXAS WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 113. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 114. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 115. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET RANKING, BY KEY PLAYER, 2022
TABLE 116. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 117. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 118. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET MERGER & ACQUISITION
TABLE 119. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 120. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 121. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET INVESTMENT & FUNDING
TABLE 122. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 123. UNITED STATES WOMEN’S HEALTH DIAGNOSTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Alere Inc.
  • Becton, Dickinson and Company
  • Biomérieux SA
  • Cardinal Health, Inc.
  • Carestream Health, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Cook Medical, Inc.
  • Danaher Corporation
  • DIALAB GmbH
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Guided Therapeutics, Inc.
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • MedGyn Products, Inc.
  • NeuroLogica Corporation
  • Nova Biomedical
  • Osteometer MediTech, Inc.
  • Perkinelmer Inc.
  • Quest Diagnostics Incorporated
  • Siemens AG
  • SuperSonic Imagine
  • WerfenLife, S.A.

Methodology

Loading
LOADING...